Skip to Main Content

COVID-19 is an emerging, rapidly evolving situation.

What people with cancer should know: https://www.cancer.gov/coronavirus

Get the latest public health information from CDC: https://www.coronavirus.gov

Get the latest research information from NIH: https://www.nih.gov/coronavirus

Here you can browse the complete list of projects on CDAS whose requests for data/biospecimens were approved.

Data-Only Studies
Biospecimen Studies
Reset

Results: 1652 (Showing 1621 to 1640) — Export these results

Name Principal Investigator Institution Study Date Approved Project ID
Chlamydia pneumoniae infection, chronic inflammation and risk of lung cancer Anil Chaturvedi NCI, DCEG, IIB PLCO Apr 21, 2006 2005-0014
Measuring carcinogen metabolite levels in long-term smokers and estimating the risk of lung cancer Timothy Church University of Minnesota PLCO Apr 21, 2006 2005-0029
Alcohol intake, genes responsible for alcohol metabolism, and risk of breast cancer in the PLCO cohort Catherine McCarty Marshfield Clinic Research Foundation PLCO Apr 21, 2006 2005-0027
Biomarkers and genetic polymorphisms of one-carbon metabolism and risk of lymphoid cancers Unhee Lim NCI, DCEG, NEB PLCO Apr 21, 2006 2005-0025
Serum 25-hydroxyvitamin D, dietary vitamin D and non-Hodgkin Lymphoma: a Nested Case Control Study in the PLCO Trial Mark Purdue NCI, DCEG, OEEB PLCO Apr 21, 2006 2005-0021
Genetic variation in the vitamin E blood transport, cellular uptake, and metabolism pathway and prostate cancer risk Demetrius Albanes Extramural PLCO Apr 21, 2006 2005-0018
Insulin Resistance-Related Metabolic Markers and Pancreatic Cancer Risk Rachael Stolzenberg-Solomon NCI, DCEG, NEB PLCO Apr 21, 2006 2005-0024
Evaluating Screening Bias in Risk Factor Studies of Lung Cancer Nested in the PLCO Trial Timothy Church University of Minnesota PLCO Mar 31, 2006 2006-0307
Observer Variability among PLCO-NLST Radiologists in Interpretation of T-1 CT Hrudaya Nath University of Alabama at Birmingham NLST Feb 20, 2006 2006-00324
Observer Variability among PLCO-NLST Radiologists in Interpretation of T-0 CXR Hrudaya Nath University of Alabama at Birmingham NLST Feb 20, 2006 2006-00391
Iron homeostasis and colorectal adenoma risk in the Prostate, Lung, Colorectal & Ovarian (PLCO) Cancer Screening Trial Amanda Cross NCI, DCEG, NEB PLCO Oct 24, 2005 2005-0012
Cell Cycle Variants and Metastatic Prostate Cancer Risk Adam Kibel Washington University PLCO Sep 23, 2005 2005-0001
Telomere length, mitochondrial DNA mass, and risk for major chronic diseases Richard Hayes New York University PLCO Aug 17, 2005 2005-0006
Chromosomal aberrations in cultured peripheral blood lymphocytes and subsequent risk of leukemia and lymphoma Nathaniel Rothman - PLCO Aug 17, 2005 2005-0002
Breast Cancer: Molecular Epidemiology in the PLCO EEMS Cohort- Nutritional Factors Regina Ziegler NCI, DCEG, EBP PLCO Aug 17, 2005 2005-0010
Phase III validation using PLCO specimens of a consensus panel of ovarian cancer biomarkers developed by SPORE/EDRN investigators Daniel W. Cramer Brigham and Women's Hospital / Harvard Medical School PLCO Aug 17, 2005 2005-0009
C-GEMS: Cancer Genetic Markers of Susceptibility A Strategic Initiative to Identify Novel Genetic Determinants of Cancer Mitchell Machiela NCI, DCEG, LGS PLCO Aug 17, 2005 2005-0003
Inflammation regulation: Gene variants and inflammatory markers in colorectal neoplasia Sonja Berndt NCI, DCEG, OEEB PLCO Aug 17, 2005 2005-0011
Multiplexed Assay of Serum Biomarkers for Pancreatic Cancer Anna Lokshin University of Pittsburgh PLCO Aug 17, 2005 2005-0008
MT1-MMP and EMMPRIN in Cigarette Smoke-Induced Lung Inflammation and Emphysema Robert Senior Washington University NLST Jul 13, 2005 2005-90026